Univest
Univest
  • Markets
  • Bandhan Medium to Long Duration Direct Quarterly IDCW: NAV Today, Performance Review and Should You Invest?

    • July 31, 2026
    • Posted by: Kunal Singla
    • Category: News
    No Comments
    Bandhan Medium to Long Duration Direct Quarterly IDCW: NAV Today, Performance Review and Should You Invest?

    Bandhan Medium to Long Duration Direct Quarterly IDCW NAV, latest returns and full review including risks and how to invest.

    read more
  • Bandhan Overnight Regular Daily IDCW: NAV Today, Performance Review and Should You Invest?

    • July 31, 2026
    • Posted by: Kunal Singla
    • Category: News
    No Comments
    Bandhan Overnight Regular Daily IDCW: NAV Today, Performance Review and Should You Invest?

    Bandhan Overnight Regular Daily IDCW NAV, latest returns and full review including risks and how to invest.

    read more
  • Bandhan Medium Duration Fortnightly Direct IDCW: NAV Today, Performance Review and Should You Invest?

    • July 31, 2026
    • Posted by: Kunal Singla
    • Category: News
    No Comments
    Bandhan Medium Duration Fortnightly Direct IDCW: NAV Today, Performance Review and Should You Invest?

    Bandhan Medium Duration Fortnightly Direct IDCW NAV, latest returns and full review including risks and how to invest.

    read more
  • Bandhan Medium to Long Duration Half yearly Regular IDCW: NAV Today, Performance Review and Should You Invest?

    • July 31, 2026
    • Posted by: Ankit Jaiswal
    • Category: Mutual Funds
    No Comments
    Bandhan Medium to Long Duration Half yearly Regular IDCW: NAV Today, Performance Review and Should You Invest?

    Bandhan Medium to Long Duration Half yearly Regular IDCW NAV, latest returns and full review including risks and how to invest.

    read more
  • Bandhan Short Duration Direct Quarterly IDCW: NAV Today, Performance Review and Should You Invest?

    • July 31, 2026
    • Posted by: Kunal Singla
    • Category: News
    No Comments
    Bandhan Short Duration Direct Quarterly IDCW: NAV Today, Performance Review and Should You Invest?

    Bandhan Short Duration Direct Quarterly IDCW NAV, latest returns and full review including risks and how to invest.

    read more
  • Bandhan Medium Duration Regular Periodic IDCW: NAV Today, Performance Review and Should You Invest?

    • July 31, 2026
    • Posted by: Ankit Jaiswal
    • Category: Mutual Funds
    No Comments
    Bandhan Medium Duration Regular Periodic IDCW: NAV Today, Performance Review and Should You Invest?

    Bandhan Medium Duration Regular Periodic IDCW NAV, latest returns and full review including risks and how to invest.

    read more
  • Bandhan Medium Duration Fortnightly Regular IDCW: NAV Today, Performance Review and Should You Invest?

    • July 31, 2026
    • Posted by: Kunal Singla
    • Category: News
    No Comments
    Bandhan Medium Duration Fortnightly Regular IDCW: NAV Today, Performance Review and Should You Invest?

    Bandhan Medium Duration Fortnightly Regular IDCW NAV, latest returns and full review including risks and how to invest.

    read more
  • Bandhan Medium to Long Duration Direct Growth: NAV Today, Performance Review and Should You Invest?

    • July 31, 2026
    • Posted by: Ankit Jaiswal
    • Category: Mutual Funds
    No Comments
    Bandhan Medium to Long Duration Direct Growth: NAV Today, Performance Review and Should You Invest?

    Bandhan Medium to Long Duration Direct Growth NAV, latest returns and full review including risks and how to invest.

    read more
  • Ajanta Pharma Q1 Results FY27: Net Profit at Rs 334 Cr for June 2026 Quarter

    • July 31, 2026
    • Posted by: Kunal Singla
    • Category: News
    No Comments
    Ajanta Pharma Q1 Results FY27: Net Profit at Rs 334 Cr for June 2026 Quarter

    Ajanta Pharma Q1 results FY27: consolidated net profit at Rs 334 Cr and revenue at Rs 1,625 Cr for the quarter ended June 2026. Direct answer plus full breakdown inside.

    read more
  • Global Health (Medanta) Q1 Results FY27: Net Profit at Rs 157 Cr for June 2026 Quarter

    • July 31, 2026
    • Posted by: Kunal Singla
    • Category: News
    No Comments
    Global Health (Medanta) Q1 Results FY27: Net Profit at Rs 157 Cr for June 2026 Quarter

    Global Health (Medanta) Q1 results FY27: consolidated net profit at Rs 157 Cr and revenue at Rs 1,304 Cr for the quarter ended June 2026. Direct answer plus full break…

    read more
  • 1
  • …
  • 1,036
  • 1,037
  • 1,038
  • 1,039
  • 1,040
  • …
  • 2,671